- E-mailLars.Sverkeli@uib.no
- Phone+47 55 58 45 62
- Visitor AddressJonas Lies vei 915009 Bergen
- Postal AddressPostboks 78045020 Bergen
Academic article
- (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 396-407.e6.
- (2021). Instability in nad+ metabolism leads to impaired cardiac mitochondrial function and communication. eLIFE. 1-23.
- (2021). Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD. Biomolecules.
- (2021). Discovery of fungal surface NADases predominantly present in pathogenic species. Nature Communications. 12 pages.
Errata
- (2021). Author Correction: Discovery of fungal surface NADases predominantly present in pathogenic species (Nature Communications, (2021), 12, 1, (1631), 10.1038/s41467-021-21307-z). Nature Communications.
Academic literature review
- (2021). The balance between NAD + biosynthesis and consumption in ageing. Mechanisms of Ageing and Development.
Article in business/trade/industry journal
- (2021). The 2021 FASEB science research conference on NAD metabolism and signaling. Aging. 24924-24930.
More information in national current research information system (CRIStin)